Literature DB >> 16357133

Akt phosphorylates and regulates Pdcd4 tumor suppressor protein.

Alexey Palamarchuk1, Alexey Efanov, Vadim Maximov, Rami I Aqeilan, Carlo M Croce, Yuri Pekarsky.   

Abstract

Programmed cell death 4 (Pdcd4) is a tumor suppressor protein that interacts with eukaryotic initiation factor 4A and inhibits protein synthesis. Pdcd4 also suppresses the transactivation of activator protein-1 (AP-1)-responsive promoters by c-Jun. The Akt (protein kinase B) serine/threonine kinase is a key mediator of phosphoinositide 3-kinase pathway involved in the regulation of cell proliferation, survival, and growth. Because Pdcd4 has two putative Akt phosphorylation sites at Ser(67) and Ser(457), we investigated whether Akt phosphorylates and regulates Pdcd4. Our results show that Akt specifically phosphorylates Ser(67) and Ser(457) residues of Pdcd4 in vitro and in vivo. We further show that phosphorylation of Pdcd4 by Akt causes nuclear translocation of Pdcd4. Using luciferase assay, we show that phosphorylation of Pdcd4 by Akt also causes a significant decrease of the ability of Pdcd4 to interfere with the transactivation of AP-1-responsive promoter by c-Jun.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16357133     DOI: 10.1158/0008-5472.CAN-05-3469

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  61 in total

1.  Protein kinase GSK3β regulates tumor suppressor Pdcd4 expression in lung cancer cells.

Authors:  P N Vikhreva; E V Korobko; I V Korobko
Journal:  Dokl Biochem Biophys       Date:  2012-03-15       Impact factor: 0.788

Review 2.  The coming of age of phosphoproteomics--from large data sets to inference of protein functions.

Authors:  Philippe P Roux; Pierre Thibault
Journal:  Mol Cell Proteomics       Date:  2013-09-13       Impact factor: 5.911

3.  13q14 deletions in CLL involve cooperating tumor suppressors.

Authors:  Alexey Palamarchuk; Alexey Efanov; Natalya Nazaryan; Urmila Santanam; Hansjuerg Alder; Laura Rassenti; Thomas Kipps; Carlo M Croce; Yuri Pekarsky
Journal:  Blood       Date:  2010-01-13       Impact factor: 22.113

4.  Enhanced arginine methylation of programmed cell death 4 protein during nutrient deprivation promotes tumor cell viability.

Authors:  Marta M Fay; James M Clegg; Kimberly A Uchida; Matthew A Powers; Katharine S Ullman
Journal:  J Biol Chem       Date:  2014-04-24       Impact factor: 5.157

5.  SUMOylation-regulated protein phosphorylation, evidence from quantitative phosphoproteomics analyses.

Authors:  Qi Yao; Hui Li; Bing-Qian Liu; Xin-Yun Huang; Lin Guo
Journal:  J Biol Chem       Date:  2011-06-17       Impact factor: 5.157

Review 6.  Regulation of interferon-dependent mRNA translation of target genes.

Authors:  Barbara Kroczynska; Swarna Mehrotra; Ahmet Dirim Arslan; Surinder Kaur; Leonidas C Platanias
Journal:  J Interferon Cytokine Res       Date:  2014-02-21       Impact factor: 2.607

7.  Development of a high-throughput cell-based reporter assay to identify stabilizers of tumor suppressor Pdcd4.

Authors:  Johanna S Blees; Tobias Schmid; Cheryl L Thomas; Alyson R Baker; Lauren Benson; Jason R Evans; Ekaterina I Goncharova; Nancy H Colburn; James B McMahon; Curtis J Henrich
Journal:  J Biomol Screen       Date:  2009-11-09

8.  Heterogeneous nuclear ribonucleoprotein C1/C2 controls the metastatic potential of glioblastoma by regulating PDCD4.

Authors:  Young Mi Park; Su Jin Hwang; Kiyoshi Masuda; Kyung-Min Choi; Mi-Ran Jeong; Do-Hyun Nam; Myriam Gorospe; Hyeon Ho Kim
Journal:  Mol Cell Biol       Date:  2012-08-20       Impact factor: 4.272

9.  Elucidating the CXCL12/CXCR4 signaling network in chronic lymphocytic leukemia through phosphoproteomics analysis.

Authors:  Morgan O'Hayre; Catherina L Salanga; Thomas J Kipps; Davorka Messmer; Pieter C Dorrestein; Tracy M Handel
Journal:  PLoS One       Date:  2010-07-22       Impact factor: 3.240

10.  Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer.

Authors:  N A Wei; Stephanie S Liu; Thomas H Y Leung; Kar F Tam; Xiao Y Liao; Annie N Y Cheung; Karen K L Chan; Hextan Y S Ngan
Journal:  Mol Cancer       Date:  2009-09-03       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.